[HTML][HTML] Phase II trial of pemetrexed and bevacizumab in patients with recurrent or metastatic head and neck cancer
Journal of Clinical Oncology, 2011•ncbi.nlm.nih.gov
Phase II Trial of Pemetrexed and Bevacizumab in Patients With Recurrent or Metastatic Head
and Neck Cancer - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI
Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text Archive
Search in PMC Advanced Search User Guide Journal List J Clin Oncol PMC3083869 Other
Formats PubReader PDF (136K) Actions Cite Collections Share Permalink Copy
RESOURCES Similar articles Cited by other articles Links to NCBI Databases Journal List J …
and Neck Cancer - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI
Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text Archive
Search in PMC Advanced Search User Guide Journal List J Clin Oncol PMC3083869 Other
Formats PubReader PDF (136K) Actions Cite Collections Share Permalink Copy
RESOURCES Similar articles Cited by other articles Links to NCBI Databases Journal List J …
Abstract
Purpose
We hypothesized that bevacizumab, a monoclonal antibody against vascular endothelial growth factor (VEGF), will potentiate the activity of pemetrexed, a multitargeted antifolate, in squamous cell carcinoma of the head and neck (SCCHN).
ncbi.nlm.nih.gov